475 - Quality of asthma care and outcomes among children in a highly rural state
Sunday, April 27, 2025
8:30am – 10:45am HST
Publication Number: 475.6482
Liyan Mazahreh, UAMS, Little Rock, AR, United States; Chary Akmyradov, Arkansas Children's Hospital, Little Rock, AR, United States; Tamara Perry, University of Arkansas for Medical Sciences College of Medicine, Little Rock, AR, United States; Stacie M.. Jones, University of Arkansas for Medical Sciences College of Medicine, Little Rock, AR, United States; Akilah A. Jefferson, University of Arkansas for Medical Sciences, Little Rock, AR, United States
Medical Student University of Arkansas for Medical Sciences College of Medicine LITTLE ROCK, Arkansas, United States
Background: Asthma is the most common chronic respiratory disease of childhood. The Asthma Medication Ratio (AMR) is a commonly used quality metric to assess asthma control, medication adherence, and outcomes with a low AMR assoicated with risk for poor asthma outcomes. A modified AMR (m-AMR), using electronic health record (EHR) data rather than claims data, has been used to assess the risk of asthma exacerbations longitudinally. Objective: This study aims to quantify the relationship between a m-AMR and adverse asthma outcomes among children in a rural state. Design/Methods: The Arkansas Children’s Hospital (ACH) EHR was used for a retrospective cohort study including children aged 0-18 years with asthma identified during any type of medical event in calendar years 2017-2020. The primary outcome was adverse asthma outcomes (asthma-related ED visits, urgent care visits, and hospitalizations) during 2017-2020. The m-AMR was calculated for each year using medication prescription records. Additionally, we evaluated the relationship between the change in m-AMR over time and adverse outcomes. Results: The cohort (n= 3430) was 60.7% male, 50.3% were 5-11 years old, 33.2% White, 49.2% Black, 17.6% Other race and ethnicity, and 13.9% Hispanic. Of those, 28.2% had an adverse outcome overall (across all years), 2.3% in 2017, 11.8% in 2018, 12.8% in 2019, 7.1% in 2020. The m-AMR varied significantly across demographic and clinical factors. Low m-AMR ( < 0.5) was significantly associated with Black race, age < 5 years, asthma-related ED visits and hospitalizations, and very low child opportunity (state-normed COI). High m-AMR (0.5) was significantly associated with English as the primary language, age >5 years, and higher COI levels. Every 0.1 unit increase in m-AMR reduced the odds of adverse outcome by 19.4% from 2017-2020.
Conclusion(s): AMR can be modified for use in EHR analysis to identify children at high-risk for asthma-related adverse outcomes. We identified significant differences in m-AMR by race, age, primary language, healtcare utilization, and child opportunity. Further, we found that increasing m-AMR was inversely associated with adverse outcomes. This study, conducted in a highly rural state, supports prior work showing that multiple non-clinical factors such as race, language, and opportunity play a role in asthma outcomes, particularly among medically and socially disadvantaged children. Future strategies should focus on population-based frameworks that address differences related to these factors and that may require population-based context for success.